Detalhe da pesquisa
1.
Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling Study.
J Infect Dis
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775628
2.
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation.
Ann Oncol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648979
3.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Ann Oncol
; 35(1): 66-76, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866811
4.
ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Ann Oncol
; 34(10): 934-945, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406812
5.
Creation of forest edges has a global impact on forest vertebrates.
Nature
; 551(7679): 187-191, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088701
6.
A comparison of several methodologies of selection index for productive and reproductive characteristics in Egyptian buffaloes.
Trop Anim Health Prod
; 55(3): 200, 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188905
7.
Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches.
Ann Oncol
; 33(9): 893-908, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777706
8.
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data.
Ann Oncol
; 33(5): 511-521, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218887
9.
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.
Ann Oncol
; 33(5): 488-499, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124183
10.
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Ann Oncol
; 33(1): 67-79, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562610
11.
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
Ann Oncol
; 33(11): 1119-1133, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963481
12.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol
; 33(5): 466-487, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176458
13.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Ann Oncol
; 33(2): 181-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839016
14.
Better self-concept, better future choices? Behavioral and neural changes after a naturalistic self-concept training program for adolescents.
Cogn Affect Behav Neurosci
; 22(2): 341-361, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570336
15.
Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis.
Osteoporos Int
; 33(8): 1643-1657, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304613
16.
[German S1 Guideline Long-/Post-COVID]. / S1-Leitlinie Long-/Post-COVID.
Pneumologie
; 76(12): 855-907, 2022 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-36479679
17.
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.
Ann Oncol
; 32(5): 620-630, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639216
18.
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331â.
Ann Oncol
; 32(5): 631-641, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539946
19.
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer.
Ann Oncol
; 32(12): 1597-1607, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487855
20.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer.
Ann Oncol
; 32(12): 1496-1510, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411693